Why don’t we have a good tuberculosis vaccine?
Freya Cook explores the development of a more effective tuberculosis vaccine and the current challenges researchers face.
vaccine
Continue reading
Breathe: A new vaccine for lung cancer
Malintha Hewa Batage reports on a new initiative involving the University of Oxford, which could revolutionise preventative cancer treatment.
Hope for HIV vaccine—antibodies protect animals against infection in pilot study
Sinibaldo Romero Arocha reports on new findings that broadly neutralising antibodies confer protection against HIV in a primate study.
Luke Jerram in Oxford: A glass history of the pandemic
Artist Luke Jerram’s glass sculpture at the History of Science Museum showcases the pioneering Oxford vaccine research, says Elvira Miceli.
Antibiotics as a double-edged sword: Beyond antimicrobial resistance
Sahani De Silva discusses the rise of antimicrobial resistance and the effects antibiotics have on development, microbiome and immunity.
Taking stock: Reflecting on our pandemic mistakes
Ashley Jackson reflects on the lessons learnt during the COVID-19 pandemic, and how we all benefit by listening to each other’s perspectives.
A Potential Breakthrough in HIV Vaccine Development
Andrew Griffiths reports on results from a small-scale clinical trial showing a potential breakthrough in HIV vaccine development.
Vaginal delivery or C-section: Does mode-of-delivery affect how we respond to vaccines as an infant?
Evie Rosette reports on recent research finding a possible link between mode-of-delivery and response to vaccines in infancy.
Have we finally found an effective vaccine against malaria?
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
Vaccine drink entering trials in Oxford
By Karen Heathcote We’ve seen and heard plenty about vaccines over the last couple of years, with news outlets all over the world proudly showing images of people receiving their COVID-19 vaccination jabs. However, a new vaccine that is about to enter its next phase of trials in Oxford won’t be administered as an injection…
- 1
- 2